|
ZNF765 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.69808611616418E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.43490005935598E-10 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
5.10702591327572E-15 |
| Stage1-vs-Stage2 |
8.962400E-01 |
| Stage1-vs-Stage3 |
5.339600E-02 |
| Stage1-vs-Stage4 |
3.798500E-02 |
| Stage2-vs-Stage3 |
1.524230E-01 |
| Stage2-vs-Stage4 |
6.705600E-02 |
| Stage3-vs-Stage4 |
5.836600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.69364522406568E-12 |
| Normal-vs-AfricanAmerican |
4.57478499527042E-12 |
| Normal-vs-Asian |
7.85170040096261E-10 |
| Caucasian-vs-AfricanAmerican |
2.308000E-01 |
| Caucasian-vs-Asian |
4.127400E-01 |
| AfricanAmerican-vs-Asian |
1.607230E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.4432899320127E-15 |
| Normal-vs-Female |
4.5852210917019E-14 |
| Male-vs-Female |
4.905000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(41-60Yrs) |
1.75415237890775E-14 |
| Normal-vs-Age(61-80Yrs) |
2.79776202205539E-14 |
| Normal-vs-Age(81-100Yrs) |
7.013400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.250590E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.574220E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.673400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.221400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.524200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.966200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.856500E-03 |
| Classical-VS-Follicular |
7.794400E-01 |
| Classical-VS-Other |
2.362600E-01 |
| Classical-VS-Normal |
4.05853128881972E-12 |
| Tall-VS-Follicular |
2.126100E-02 |
| Tall-VS-Other |
9.564400E-01 |
| Tall-VS-Normal |
9.54791801177635E-15 |
| Follicular-VS-Other |
3.443600E-01 |
| Follicular-VS-Normal |
1.98796534789381E-12 |
| Other-VS-Normal |
1.198390E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.7430501486615E-14 |
| N0-vs-N1 |
1.042220E-01 |
|
|
